![Alí Duarte, MD Profile](https://pbs.twimg.com/profile_images/969596649076023297/E_Yq5ELw_x96.jpg)
Alí Duarte, MD
@AliDuarteMD
Followers
3K
Following
4K
Statuses
2K
Rheumatologist @mayoclinic | #Lupus & #APS | Clinical lead, LUMEN💡- Lupus Midwest Network | Tweets my own | 🇲🇽in🇺🇸
Mayo Clinic
Joined February 2018
Whoa! I love it! @DrGabrielFP
We had so much fun recording this week's @RheumMadness podcast to talk about our #RheumMadness scouting report on "Steroid Dose in Lupus Nephritis"! You can find our scouting report here: .. and the first half of the "Full Court Care Champions" (1/2)
0
1
6
RT @LaceyFeigl: We had so much fun recording this week's @RheumMadness podcast to talk about our #RheumMadness scouting report on "Steroid…
0
6
0
The main issue with this study is that clinicians use the CLE and SLE ICD-10 codes interchangeably. So, many people with cutaneous lupus ICD-10 codes actually have SLE.
It is established that systemic #lupus erythematosus patients are screened for #cardiovascular disease, but what about CLE patients? Our very own Professor Dr. Ben Chong and a team of #UTSW researchers made a surprising discovery. Read here: #DermTwitter
0
0
1
RT @CAgovernor: Firefighters from Mexico just arrived at LAX. They'll be joining 14,000+ personnel already battling the #PalisadesFire. Ca…
0
10K
0
🇲🇽
NEW: Firefighters from Mexico are en route to the #EatonFire — joining more than 10,000 personnel already on the ground. California is deeply grateful for President @ClaudiaShein's support as we work to suppress the Los Angeles wildfires. Our partnership and shared commitment to helping communities in need is greatly valued.
0
0
2
🚨 New Review Alert! 🚨 Dive into the evolving landscape of glucocorticoid therapy for lupus nephritis: 🔍 Historical shifts from high-dose to safer, low-dose strategies 🧬 Mechanisms, efficacy, & risks explored ⚖️ Balancing treatment efficacy with long-term safety
Now online in @NDTsocial Optimal Glucocorticoid Therapy in Lupus Nephritis 🧐The review examines different dosing strategies, including IV pulse and oral regimens, and presents evidence of their efficacy and safety. ▶️
1
14
45
Another well-deserved feather in Dr. Figueroa’s cap!
🧵 1/6 New research alert! 🚨 Our most recent LUMEN (💡) paper explores the utility of the 2019 EULAR/ACR SLE classification criteria in predicting mortality and hospitalization in patients with SLE. #LupusResearch #SLE.
0
0
11
RT @ElHasbaniG: It was a great pleasure to have Dr. @jasonsknight as the Boland Visiting Professor at the Mayo Clinic Rheumatology. Thank y…
0
1
0